Navigation Links
Central Texas Hospital Selects eCareSoft EHR Technology
Date:4/5/2011

AUSTIN, Texas, April 5, 2011 /PRNewswire/ -- eCareSoft announced today the completion of an agreement with Central Texas Hospital (CTH) to connect their network of six hospitals with eCareSoft's inpatient complete EHR and revenue cycle management technology.

CTH will incorporate eCareSoft's proprietary fast-track implementation program enabling their hospital network to expedite their 'meaningful use' activities in order to qualify for 2011-2012 stimulus funds.

"We are very pleased to be a part of Central Texas Hospital's electronic health records strategy," said Jorge Camargo, CEO of eCareSoft.  "Their interest in connecting their six hospitals with our technology is further validation that we are on the right path with our integrated solutions for small hospitals," added Camargo.

Many small and rural hospitals continue to face financial, technical and manpower challenges in transitioning to EHR solutions. eCareSoft offers a turnkey solution of technology, support and training for a fraction of the cost associated with traditional implementations. Using the company's fast-track implementation program, small hospitals can rollout the technology necessary to meet 'meaningful use' in as few as 120 days versus the traditional 8-12 months.

"Transitioning to electronic health records is an important step for us, not only to improve efficiencies across our hospital network, but to advance our goal of providing the highest level of patient care to our communities," stated Joe White, CFO Central Texas Hospital.  "eCareSoft offered us an expedited path to achieving 'meaningful use' and a flexible solution that really seemed to fit our small hospital environments," added White.

eCareSoft's EHR is an ONC-ATCB certified complete inpatient solution that utilizes a shared patient-centric database configuration rather than facilities centric, eliminating the redundant inputting of patient historical information each time an event
'/>"/>

SOURCE eCareSoft
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves Gadavist for Central Nervous System Scans
2. U.S. FDA Approves Bayers Gadavistâ„¢ (Gadobutrol) Injection for MRI of the Central Nervous System
3. Mithridion, Inc. Announces New Funding and Outlines Strategy for Central Nervous System Drug Development
4. Reportlinker Adds The Outlook for Pharmaceuticals in Central Asia
5. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
6. Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME)
7. Cipher Pharmaceuticals Using MedAvante Centralized Ratings in Phase 3 Study
8. Rexahn to Use MedAvante Centralized Ratings in MDD Phase 2b Study
9. Wound Management Technologies Adds Panama to Growing List of Distribution Points in Central America
10. FDA Approves NDA That Includes Psychiatric Data Collected by Centralized Raters
11. Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, ... the Journal of Drugs in Dermatology (JDD) ... (ODAC). The event is January 17-20, 2014, at the Omni Orlando ... The ODAC is a distinguished event ...
(Date:1/15/2014)... Jan. 15, 2014  In an unprecedented effort to curb the spread ... and other transport vehicles, an advanced and portable UV germicidal lamp ... the first time. In order to prevent EMS ... pathogens, West Palm Beach Fire Rescue is ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading ... to release its second quarter 2011 financial results on Tuesday, ... financial markets.  The Company will also host a conference call ... 2011 to discuss its financial results and provide an update ...
... CHADDS FORD, Pa., June 30, 2011 Endo Pharmaceuticals (Nasdaq: ... phase 2 study comparing the novel investigational drug axomadol against ... chronic low back pain. The results indicate that axomadol did ... completing additional analyses of the data and evaluating the path ...
Cached Medicine Technology:Watson to Host Conference Call and Webcast to Discuss Second Quarter 2011 Earnings 2Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain 2
(Date:4/17/2014)... 17, 2014) Two recent papers by a ... colleagues may help scientists develop treatments or vaccines ... Japanese encephalitis and other disease-causing flaviviruses. , Jeffrey ... molecular genetics at the School of Medicine and ... Medical Institute, and colleagues recently published articles in ...
(Date:4/17/2014)... Le Bonheur Children,s Hospital Pediatrician-in-Chief Jon McCullers, MD, ... the April issue of Nature Reviews Microbiology ... Dr. McCullers, a world-renowned infectious disease specialist, ... the University of Tennessee Health Science Center, analyzed ... 1918, 1957 and 1968 pandemics, as well as ...
(Date:4/17/2014)... military personnel who served in Iraq and Afghanistan ... injury (TBI) were compared to military personnel without ... Differences in measures of overall disability, cognitive function, ... are reported in an article in Journal ... Ann Liebert, Inc., publishers. The article is available ...
(Date:4/17/2014)... as many as 10 million older Americans suffer from ... isolation. , However, new research a project that ... for six years found that Internet use among ... more than 30 percent. , "That,s a very strong ... of telecommunication, information studies and media who led the ...
(Date:4/17/2014)... April 17, 2014-- Colic affects about one in five ... numerous pediatric visits during the first several months after ... symptoms was showing promise; however, the April 1, 2014 ... Sung, Valerie) reported on a study, "Probiotics and Infant ... L reuteri for infant colic did not ...
Breaking Medicine News(10 mins):Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Internet use can help ward off depression among elderly 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... love and addiction may go hand in hand due ... as a result of dopamine release// (neurotransmitter) after having ... of the effects observed following drug abuse with cocaine ... leaves the user with an insatiable feeling, probing for ...
... Cardiac rehabilitation program with safe and tolerable exercise can ... which help them to have a better heart function//. ... the supervision of Cardiologist, Jonathan Rhodes. ,The ... group of 8 to 17 with severe congenital heart ...
... the coffee cap proposed by a study by Florian Koppelstatter, ... cup of coffee with 100 mg caffeine can boost short-term ... 15 healthy men aged 26 to 47. Participants were tested ... consumed a placebo. 100 mg caffeine can be found in ...
... Austrian researchers at the annual meeting of the Radiological ... that caffeine has the ability to boost short-term memory// ... control this activity. ,Caffeine is normally found ... chocolate. The researchers tested 15 subjects who had just ...
... called Sonam was born with a hearing in both ears in ... completing her first year as result of a successful cochlear implant ... shortcoming when she was three months old. But they did not ... down the line, she behaves like any other normal child. ...
... Bill Gates, Chief of Microsoft, will visit India on 6 ... will be among the cities he will visit as he ... India//. ,India figures very high on the priority list ... him sharing his IT vision as he interacts with key ...
Cached Medicine News:Health News:Love And Drug Addiction Share The Same Chemistry 2Health News:Early Intervention Required For The Hearing Impaired 2Health News:Bill Gates Takes Personal Interest in AIDS Program 2
MagaCell-Streptavidin is a streptavidin coupled to magnetizable cellulose/iron oxide particles...
BioVintages Biotin-Trapper™ Streptavidin Magnetic Beads (1 mm - 2 mm) are designed for single-step capture of biotinylated molecules such as DNA, RNA or protein from cell lysates or hybridizatio...
... is a method for isolating antibodies, ... cells using affinity binding, while retaining ... on the particles to separate biotinylated ... the MagnaBind™ Beads from the suspension, ...
... m Dynabeads with covalently bound ... any biotinylated target. The Dynabeads® ... area, high capacity, magnetic pull ... during incubation. The MyOne™ products ...
Medicine Products: